Cargando…
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
AIMS/HYPOTHESIS: Fulminant type 1 diabetes (FT1D) is a distinct subtype of type 1 diabetes and is fatal without immediate diagnosis and treatment. At present, there are no biomarkers for early and predictive detection of FT1D. METHODS: First, we analyzed a total of 6 serum samples from 3 patients wi...
Autores principales: | Haseda, Fumitaka, Imagawa, Akihisa, Nishikawa, Hiroyoshi, Mitsui, Shinobu, Tsutsumi, Chiharu, Fujisawa, Reiko, Sano, Hiroyuki, Murase-Mishiba, Yuko, Terasaki, Jungo, Sakaguchi, Shimon, Hanafusa, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981355/ https://www.ncbi.nlm.nih.gov/pubmed/27513516 http://dx.doi.org/10.1371/journal.pone.0160576 |
Ejemplares similares
-
Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel α-Cell Model of Insulin-Deficient Diabetes
por: Bessho, Megumi, et al.
Publicado: (2014) -
Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
por: Murase-Mishiba, Yuko, et al.
Publicado: (2008) -
Endogenous insulin secretion even at a very low level contributes to the stability of blood glucose control in fulminant type 1 diabetes
por: Shibasaki, Saeko, et al.
Publicado: (2010) -
“Preserved” glucagon secretion in fulminant type 1 diabetes
por: Murase‐Mishiba, Yuko, et al.
Publicado: (2018) -
Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies
por: Tsutsumi, Chiharu, et al.
Publicado: (2011)